Here, to assess the impairment that the extra exogenous/latent variables possibly inflict on null-hypothesis testing, we repeated the procedure not just under the same conditions of [19], but also using a broader range of data record sizes: begin{aligned} K={100,,200,,500,,1000,,2000,,5000,,10000}.
Moreover, in the secondary data, the conditions of the patients recorded at the beginning of data collection might have changed by the time of the hip fracture and thus could affect the accuracy and reliability of the study results.
We begin by analyzing the treatment-emergent adverse events (TEAEs) and vital signs data recorded in clinical trials of LDX, of both short- and longer-term duration.
Anonymised clinical and demographic data recorded in GPs' electronic health records between 1 April 2008 and 1 April 2013 were extracted using EMIS web software for all patients aged 30 years and over at the beginning of the study period.
At the beginning of each trial, the startRecording method was called to start data recording, and at the end of each trial, the stopRecording method was called to stop recording.
We excluded vocal sequences that occurred within 30 s of the beginning or end of the data record, which removed 40 vocal sequences initiated by male vocalizations and 17 vocal sequences initiated by female vocalizations from the analysis.
We excluded potential trigger vocalizations that occurred within 30 s from the beginning or end of the data record (141 male and 3 female vocalizations).
